Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn’s Disease: An Observational Study

Table 2

Patients’ characteristics and HBOT effect according to indication.

Characteristic	pCD	ECF	PG
Age (at CD onset)
(years)				0.87
Age (at HBOT)
(years)				0.83
CD duration
(years)				0.95
Duration of anti-TNF therapy
(months)				0.81
Number of HBOT sessions
				0.98
Complete healing rate
(%)	20 (80.0)	11 (84.6)	6 (100.0)	0.38

pCD: perineal fistulizing Crohn’s disease; ECF: enterocutaneous fistula; PG: pyoderma gangrenosum; CD: Crohn’s disease; SD: standard deviation; HBOT: hyperbaric oxygen therapy. ANOVA test. Pearson chi-square test.